Tissue microarray sampling strategy for prostate cancer biomarker analysis.
Rubin MA, Dunn R, Strawderman M, Pienta KJ
Purpose
The purpose of this paper was to determine the optimal number of cores on a tissue microarray (TMA) to accurately represent ki-67 immunohistochemical (IHC) staining and predict prostate cancer outcome.
Conclusion
Sampling of 3 cores was necessary to overcome the variability in ki-67 expression, but additional cores did not increase reliability of the measurement. Prediction of outcome was highly significant when 3 or more cores were stained, and while low variability in outcome predictions was observed when at least 4 cores were stained, the addition of more cores did not decrease variability.
Studies (1)
Purpose
The purpose of this study was to determine the optimal number of cores on a TMA to accurately represent ki-67 IHC staining and predict prostate cancer outcome. The authors record expression level based on the 90th percentile of the 10 measurements taken per sample. The ki-67 expression study included only one specimen that was divided into 10 sections from each of which 5 cores were obtained. The outcome study included 6-10 cores taken from each of 88 cases.
Summary of Findings
Sampling of 3 cores was necessary to overcome the variability in ki-67 expression, but additional cores did not increase reliability of the measurement. Prediction of outcome was highly significant when 3 or more cores were stained, and while low variability in outcome predictions was observed when at least 4 cores were stained, the addition of more cores did not decrease variability.
Biospecimens
TissueProstatePreservation Types
FormalinDiagnoses
NeoplasticCarcinomaPlatforms
ProteinImmunohistochemistryProteinTissue microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Aliquot size/volume 1 core2 cores3 cores4 cores5 cores6-10 coresBiospecimen Aliquots and Components Type of slide Tissue microarrayWhole tissue sectionImmunohistochemistry Specific Targeted peptide/protein Ki-67